Novo Nordisk defends next-gen obesity drug CagriSema, details new trial
Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...
The Financial Times26d
LVMH overtakes Novo Nordisk as Europe’s most valuable company
Simply sign up to the European companies myFT Digest -- delivered directly to your inbox. Luxury goods maker LVMH regained its crown as the largest company in Europe on Friday, after shares in ...
Yahoo Finance22d
LVMH dethrones Novo Nordisk as Europe’s most valuable company as Bernard Arnault adds $12 billion to net worth in 2025
Luxury fashion house LVMH has reclaimed its title as Europe’s most valuable company from Novo Nordisk, as early signs of a luxury comeback coincided with fresh struggles for the Danish Ozempic ...
Yahoo Finance25d
LVMH Regains Title of Europe’s Most Valuable Stock From Novo
(Bloomberg) -- It’s taken LVMH nearly a year-and-a-half to wrestle back its spot as Europe’s biggest stock from Novo Nordisk A/S. The Danish drugmaker’s shares fell 4.3% on Friday after its ...